Ceres Nanosciences has developed and commercialized a novel nanoparticle technology, the Nanotrap, which provides biomarker capture and biofluid sample processing capabilities for a wide array of diagnostic applications and sample handling needs.
Company (Alive / Active)
9460 Innovation Drive
Virginia, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)